Synthetic α-Helical Peptides as Potential Inhibitors of the ACE2 SARS-CoV-2 Interaction.
Pascal M EngelhardtSebastián Florez-RuedaMarco DrexeliusJörg-Martin NeudörflDaniel LausterChristian P R HackenbergerRonald KühneInes NeundorfHans-Günther SchmalzPublished in: Chembiochem : a European journal of chemical biology (2022)
During viral cell entry, the spike protein of SARS-CoV-2 binds to the α1-helix motif of human angiotensin-converting enzyme 2 (ACE2). Thus, alpha-helical peptides mimicking this motif may serve as inhibitors of viral cell entry. For this purpose, we employed the rigidified diproline-derived module ProM-5 to induce α-helicity in short peptide sequences inspired by the ACE2 α1-helix. Starting with Ac-QAKTFLDKFNHEAEDLFYQ-NH 2 as a relevant section of α1, a series of peptides, N-capped with either Ac-βHAsp-[ProM-5] or Ac-βHAsp-PP, were prepared and their α-helicities were investigated. While ProM-5 clearly showed a pronounced effect, an even increased degree of helicity (up to 63 %) was observed in sequences in which non-binding amino acids were replaced by alanine. The binding affinities of the peptides towards the spike protein, as determined by means of microscale thermophoresis (MST), revealed only a subtle influence of the α-helical content and, noteworthy, led to the identification of an Ac-βHAsp-PP-capped peptide displaying a very strong binding affinity (K D =62 nM).
Keyphrases
- sars cov
- angiotensin converting enzyme
- amino acid
- angiotensin ii
- single cell
- dna binding
- respiratory syndrome coronavirus
- binding protein
- cell therapy
- endothelial cells
- photodynamic therapy
- stem cells
- protein protein
- mesenchymal stem cells
- atomic force microscopy
- climate change
- small molecule
- coronavirus disease
- high speed